Technical Analysis for MRSN - Mersana Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 1.71 3.64% 0.06
MRSN closed down 0.6 percent on Friday, October 18, 2019, on 57 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical MRSN trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 3.64%
Boomer Buy Setup Bullish Swing Setup 3.64%
Narrow Range Bar Range Contraction 3.64%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 3.01%
Inside Day Range Contraction 3.01%
Up 3 Days in a Row Strength 3.01%
Crossed Above 20 DMA Bullish 4.91%
20 DMA Resistance Bearish 9.62%
New Uptrend Bullish 9.62%
1,2,3 Pullback Bullish Bullish Swing Setup 9.62%

Older signals for MRSN ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Mersana Therapeutics, Inc. is a United States-based biotechnology company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs). The Company focuses on advancing a pipeline of targeted oncology therapeutics leveraging its Fleximer immunoconjugate technology. The Fleximer platform allows it to design ADCs with specific properties and manage the drug's chances of attacking cancers. Its product candidates include XMT-1522 and XMT-1536. The ADC therapies treat cancer patients by engineering a drug conjugate with various anti-cancer agents and controlling when, where and how those agents are released. Dolaflexin is its Fleximer antibody drug conjugation platform, which pairs the Fleximer polymer with its linker chemistries to create ADC therapies. XMT-1522 is based on its Dolaflexin platform and has over 15 auristatin molecules per antibody. XMT-1522 is in Phase I clinical trial for various indications of cancers. XMT-1536 is in pre-clinical development.
Medicine Biotechnology Cancer Immunology Cancers Chemotherapy Monoclonal Antibodies Antibody Drug Conjugates Adc
Is MRSN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 8.06
52 Week Low 1.4
Average Volume 284,345
200-Day Moving Average 4.0171
50-Day Moving Average 2.0441
20-Day Moving Average 1.568
10-Day Moving Average 1.547
Average True Range 0.1457
ADX 36.71
+DI 22.7284
-DI 16.116
Chandelier Exit (Long, 3 ATRs ) 1.4829
Chandelier Exit (Short, 3 ATRs ) 1.8371
Upper Bollinger Band 1.7192
Lower Bollinger Band 1.4168
Percent B (%b) 0.77
BandWidth 19.285714
MACD Line -0.1307
MACD Signal Line -0.1877
MACD Histogram 0.0571
Fundamentals Value
Market Cap 37.48 Million
Num Shares 22.7 Million
EPS -16.23
Price-to-Earnings (P/E) Ratio -0.10
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.74
Resistance 3 (R3) 1.74 1.70 1.73
Resistance 2 (R2) 1.70 1.68 1.71 1.72
Resistance 1 (R1) 1.68 1.67 1.69 1.68 1.71
Pivot Point 1.64 1.64 1.65 1.65 1.64
Support 1 (S1) 1.62 1.62 1.63 1.62 1.59
Support 2 (S2) 1.58 1.61 1.59 1.58
Support 3 (S3) 1.56 1.58 1.58
Support 4 (S4) 1.56